Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCD4 is an ATP-binding cassette (ABC) transporter protein of the subfamily D, originally thought to be peroxisomal but now recognized as a lysosomal membrane protein critical for vitamin B12 (cobalamin) metabolism. ABCD4, in association with LMBD1, facilitates the ATP-dependent export of cobalamin from the lysosomal lumen into the cytosol, enabling its subsequent conversion into active cofactors for essential metabolic enzymes. Mutations in ABCD4 result in failure of cobalamin release, leading to rare inherited metabolic disorders characterized by B12 deficiency, with major hematological and neurological consequences. The protein is unique among mammalian ABC transporters for functioning as an importer of a soluble compound into the cytoplasm, contrasting with other members of its subfamily that localize to peroxisomes and mediate fatty acid transport.
ATPase-dependent translocation of cobalamin across the lysosomal membrane from the lumen to the cytosol
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family D member 4 (ABCD4).